C haracterized by recurrent panic attacks, PD involves a wide range of bodily sensations and increased levels of anxiety or discomfort. Because respiratory symptoms such as hyperventilation, dyspnea, a feeling of choking, and breathlessness are prominent during panic attacks, respiration has been one of the most widely studied physiological parameters in PD patients. Some respiratory challenges have been developed that make it possible to investigate the relation between PD and the respiratory system. In addition to findings from clinical descriptions of PD patients, 1 studies investigating the response to respiratory challenges provide evidence for a respiratory subtype of PD with distinct etiological pathways. According to Rassovsky et al, 2 abnormalities on certain respiratory parameters may prove to be markers of subgroups within the panic population. Beck et al 3 found that, despite equivalent increases in anxiety and panic symptoms, PD respiratory and PD nonrespiratory subgroups were different in respiratory functioning during and after a 12% oxygen challenge, the former having greater fluctuation in tidal volume. A comprehensive review on PD found that respiratory PD patients had significantly lower resting end-tidal carbon dioxide than the cognitive PD subgroup and control subjects. 4 This suggests that measures of respiration may adequately distinguish the respiratory subtype profile and add value to the discriminative ability of a specific respiratory pattern in PD patients. Consequently, respiratory patterns may play an important role in the early diagnosis of the respiratory PD subtype and in determining adequate treatment.
Interestingly, there appears to be another important finding from the investigation of respiratory measures that may be able to discriminate between different anxiety disorders involving panic attacks. The anxiety reported by PD patients in response to a 5% carbon dioxide challenge is accompanied by a larger increase in respiratory rate than in control subjects or people with social phobia. 5 Slower respiratory symptomatic recovery and lower partial pressure of carbon dioxide recovery in PD patients, compared with social phobia and control subjects were also found after voluntary hyperventilation. 6 Studies on respiratory rate, tidal volume, minute ventilation, or partial pressure of respiratory gases show that PD patients have different patterns during both rest and sleep. 7, 8 Studies including a baseline period preceding respiratory tests have reported lower resting partial pressure of carbon dioxide levels in PD patients than in control subjects, measuring it through capnography in one study (end-tidal carbon dioxide) 9 and directly from venous blood in another study. 10 PD patients undergoing a 5% carbon dioxide challenge showed specific baseline symptom levels (dyspnea and fear) that were associated with no panic or panic outcome. 11 However, specific respiratory patterns in PD patients are not a consistent finding in the literature, and different challenge procedures may partially account for this. It may very well be that slight changes in the course of physiological variables are masked by the use of more potent respiratory challenges. Moreover, the challenges currently in use directly affect respiration, but the magnitude and the means by which they do differ substantially, forcing physiological parameters in different directions. Specifically, it is well known that whereas inhalation of carbon dioxide is a hypercapnic challenge, the voluntary hyperventilation test provokes hypocapnia by increasing the respiratory rate. Therefore, investigating the phase following a respiratory challenge may be more appropriate to establish respiratory differences between PD and control subjects, than the challenge phase itself. Only a few studies in the literature have investigated the recovery phase; some findings report a slower recovery of partial pressure of carbon dioxide, heart rate, and skin conductance in PD patients than in control subjects and the presence of breathing irregularities (length of breathing pauses) during recovery. 6, 12 It has been noted that PD patients continue to hyperventilate during the recovery phase of a 5% carbon dioxide challenge. Unlike the controls, the patients showed a delay in lowering their minute ventilation, which resulted in a more prolonged drop in end-tidal carbon dioxide. 9 Thus physiological parameters during recovery appear to be able to distinguish PD patients from control subjects and to provide insight into possible respiratory disturbances in this particular patient group.
The aim of our study was to investigate the recovery phase from a 35% carbon dioxide challenge in PD patients and controls, and to test the hypothesis that PD patients show a different physiological pattern in response to the challenge. The inclusion of medicated PD patients provided an opportunity to test whether respiratory disturbance is a state marker of PD.
Methods

Patients and Control Subjects
Eleven nonmedicated PD patients (7 women; mean age 36 years, SD 14) with or without agoraphobia, 11 medicated PD patients (6 women; mean age 47 years, SD 13), and 11 control subjects matched for sex (7 women; mean age 33 years, To be included in the study, participants had to be aged between 18 and 65 years and naive to the 35% carbon dioxide challenge. Participants were excluded if they had significant medical illnesses, such as current or past cardiac, circulatory, or respiratory disorders, personal or family history of cerebral aneurysm, epilepsy, or if they were pregnant. All participants were in good health. Particpants were instructed to refrain from drinking coffee and alcohol the evening before the test day. The study was approved by the medical ethics committee of the Academic Hospital Maastricht, Maastricht University, and written informed consent was obtained from all participants prior to the start of the study.
Procedure
The study took place at the Academic Anxiety Center, Maastricht (the Netherlands). Patients who applied for treatment were asked to participate in the study. Volunteer control subjects were recruited through advertisements and word of mouth. Both oral and written information was provided to the control subjects before participation.
Participants were asked to sit in a comfortable armchair and to complete the POMS, the PSL, and electronic version of the VAAS with the label anxiety or discomfort. The latter consisted of a Compaq Tablet PC with touch screen. The VAAS was represented by a horizontal bar on which subjects could indicate their anxiety level. The scale ranged from 0 (no fear or discomfort at all) to 100 (the worst imaginable fear or discomfort). The electronic version of the VAAS shows a high correlation with the paper version (r = 0.98). 14 As mental load has been shown to influence respiratory frequency and, consequently, partial pressure of carbon dioxide, 15 the scales were presented to the participants before starting the experiment to familiarize them with the procedure. Subjects had to inhale at least 80% of their vital capacity, which was assessed at the beginning of the session by means of a respirometer (Wright haloscale respirometer, Ferraris Respiratory, Hertford, GB). All participants were told they would inhale a harmless mixture of 35% carbon dioxide and 65% oxygen in a single inhalation, after which they might experience some physical reactions that would disappear within a few minutes.
The experiment consisted of 3 phases during which participants would breathe through a mask. In the first, the baseline phase (10 minutes), the participants would breathe room air. The second phase, the challenge phase, consisted of one vital capacity inhalation of a gas mixture of 35% carbon dioxide and 65% oxygen ; the participants had to hold their breath for 4 seconds and then exhale. In the third phase, the recovery phase (10 minutes), the participants once again would breathe room air. Blood pressure, heart rate, respiratory rate, and end-tidal partial pressure of carbon dioxide were measured every minute during the entire session except for the first 2 minutes of recovery from the carbon dioxide challenge, during which they were measured every 10 seconds. All participants succeeded in inhaling 80% of their vital capacity at their first attempt. Blood pressure and heart rate were determined by means of a sphygmomanometer and a photoplethysmograph, respectively. Exhaled air for end-tidal partial pressure of carbon dioxide and respiratory rate measurements were taken by a small nasal cannula sensor. A soft plastic mask was placed over the participants' nose and mouth to ensure that all exhaled air passed by the end-tidal partial pressure of carbon dioxide sensor, which was connected to a capnograph (Capnomac Ultima, Datex Instrumentarium Corporation, Helsinki, FI). The electronic VAAS was scored every 8 seconds for the first 2 minutes following the challenge and every minute during the baseline and the rest of the recovery phase. Participants were asked to complete the PSL and POMS at the end of the baseline period and 2 minutes after the carbon dioxide challenge; their responses to the PSL referred to their worst moment during the challenge. Participants were asked not to talk during the session to avoid disturbing fluctuations on physiological measurements. The criteria for a panic attack was an increase of at least 25 units in the electronic VAAS and an increase in at least 4 symptoms on the PSL. The standard procedure for the 35% carbon dioxide challenge does not include asking the participants if they had experienced a panic attack at the end of the procedure. We did rely on the PSL and the electronic VAAS. However, in the past, there have been investigations showing a close resemblance between the 35% carbon dioxide-induced and real-life panic attacks.
Data Analysis
A repeated measures design ANOVA was used to analyze differences in partial pressure of carbon dioxide, respiratory rate, heart rate, and blood pressure during baseline and 2 phases of recovery within groups. Analyses included 10 consecutive time points during the baseline period (when measurements were taken every minute), the first 2 minutes of recovery (when the measurements were taken every 10 seconds), and during the last 8 minutes (measurements every minute). To correct for baseline values, the means of the 10 measurements during baseline period were subtracted from the recovery points. The resulting delta values were analyzed with a repeated measure design ANOVA. MANOVA was calculated on physiological measures to compare the groups at single points in time during baseline and recovery. In consideration of the small number of participants in each group, the Mann-Whitney test was performed to analyze the within-subject SD for measures of partial pressure of carbon dioxide, respiratory rate, and heart rate to investigate variability. The Kruskal-Wallis test was used to analyze scores from the PSL and POMS among groups. A chi-square test was applied to compare panic attack frequency following the carbon dioxide challenge. Spearman's correlations were performed to examine the strength of the relation between the physiological parameters and anxiety levels. We chose not to include analyses involving respiratory subgroups. As the group sizes were already modest, further distinguishing in respiratory and non-respiratory subgroups would result in a lack of power. All data analyses were performed with SPSS 13 software (SPSS Inc, Chicago, IL). Alpha was set at a significance level of 0.05.
Results
There were no significant differences in age, sex, or smoking habits between nonmedicated PD patients and control subjects. As medicated PD patients were older than nonmedicated patients and control subjects, age was included as a covariate. The frequency of naturally occurring panic attacks in nonmedicated and medicated patients before the treatment was 3.2 (SD 2.2) per week. The mean baseline partial pressure of carbon dioxide, respiratory rate, heart rate, and blood pressure and the electronic VAAS mean scores were not significantly different between the 3 groups. Analysis of respiratory variability showed no difference between the groups in respiratory variables during baseline. Baseline PSL scores were significantly higher in all PD patients than in control subjects ( 2 = 10.18, df = 2, P = 0.006), but medicated PD patients did not differ from the other 2 groups.
Fifty-five percent of the nonmedicated PD patients and 45% of the medicated patients had a panic attack in response to the challenge, while only 11% of the control subjects reported having one. Analysis of the recovery phase did not show significant differences in partial pressure of carbon dioxide, respiratory rate, blood pressure, or heart rate among the groups when corrected for baseline values. A trend toward time by group interaction for heart rate (F = 1.70, df = 11,220, P = 0.07) was found, with nonmedicated patients having higher values than the other 2 groups, and medicated patients having a pattern of recovery similar to that of control subjects (Figure 1 ). As a conservative approach was preferred, no further analyses were performed on trend-significant data. A significant difference in variability of partial pressure of carbon dioxide (z = -2.28, P = 0.03) and respiratory rate (z = -2.20, P = 0.03) was found between nonmedicated PD patients and control subjects during recovery (Figures 2 and  3) ; medicated PD showed no different respiratory variability, compared with control subjects. The electronic VAAS scores were significantly higher in PD patients during the first 6 minutes of recovery than in control subjects. This difference disappeared when corrected for baseline, whereas a significant interaction group by time (F = 3.02, df = 7,140, P = 0.005) emerged. A trend toward a significant difference in the electronic VAAS between pre-and post-challenge was found between PD patients and control subjects (z = -1.86, P = 0.06). PSL scores were significantly increased in the post-inhalation, compared with the pre-inhalation condition for both the PD group (z = 2.94, P = 0.003) and the control group (z = 2.8, P = 0.005). Correlations between respiratory measures and the electronic VAAS score did not reach significance.
Discussion
The current results show that PD patients have a different physiological response to a strong disturbance in homeostasis as induced by the 35% carbon dioxide challenge. Nonmedicated patients had significantly increased variability in respiratory rate and partial pressure of carbon dioxide during recovery, compared with medicated PD patients and control subjects. Moreover, nonmedicated PD patients had a higher heart rate in response to the challenge and needed more time to recover than control subjects.
The increased variability in respiratory parameters is in line with results from previous studies that investigated the respiratory physiology of PD patients. 16, 17 Variability in respiratory rate and partial pressure of carbon dioxide refers to an increased irregularity in the respiratory functioning of PD patients. It has been suggested that respiratory irregularities may indicate a state of instability in the respiratory homeostasis. 18 According to these authors, the respiratory irregularity in PD patients may arise from a complex abnormality in the integration of the brainstem neural circuits that regulate physiological homeostatic functions. Difficulties in regulating the respiratory rate and partial pressure of carbon dioxide after being disrupted by a respiratory challenge suggest an increased vulnerability of the autonomic system in PD patients. Impaired function of the autonomic system may be one of the trait markers of PD. Additional evidence for a dysfunction of the autonomic nervous system in PD, especially in the cardiovascular autonomic system, has been found before. 19 Variability in partial pressure of carbon dioxide was significantly different between nonmedicated PD patients and the other groups after 2 minutes of recovery, whereas no significant difference was found during the first 2 minutes. It is likely that, during the immediate phase of recovery, the partial pressure of carbon dioxide alteration provoked by the carbon dioxide inhalation masked differences among the groups. The strength of the stressor and the large amount of inhaled carbon dioxide obviously influenced the partial pressure of carbon dioxide in all subjects. Therefore, all participants responded strongly to the stressor and needed time to expel the excess carbon dioxide. Early evidence shows that the 35% carbon dioxide challenge induces an immediate hypercapnia that lasts for about 7 to 16 seconds after exhalation. 20 The high carbon dioxide concentration in the body is followed by a hypocapnic overshoot which, in control subjects, needs at least 60 seconds to reestablish normocapnia. This natural physiological reaction may result in a similar disruption of partial pressure of carbon dioxide in both PD patients and control subjects during the initial recovery from the challenge. A higher variability in respiratory measures in PD patients, compared with control subjects, was also found by Caldirola et al 16 in an elegant study focusing on complexity of respiratory dynamics. These authors investigated the breath-by-breath complexity of respiration dynamics in PD patients during the resting condition. Although we did not find increased variability during baseline, possibly owing to the small sample size, we did find increased respiratory variability in PD patients after a specific challenge, namely, the 35% carbon dioxide inhalation. The fact that differences emerged only after the stressor was applied may indicate that the carbon dioxide challenge magnifies subtle differences in respiratory parameters. The 35% carbon dioxide inhalation perturbs the homeostatic equilibrium and subsequently challenges the respiratory impairment of PD patients, which then becomes evident during the recovery period.
Our study has some limitations that need to be acknowledged. Medicated PD patients were treated with SSRIs, mainly Citalopram or Paroxetine. However, more specific effects of different types of SSRIs on the response to the challenge and physiological recovery were not investigated as it did not constitute the aim of the study. Patients were on medication long enough that some therapeutic effect might have been expected. Unfortunately, we did not verify the exact status at the time of testing.
Results from studies using other respiratory challenges are consistent with the dysregulation of the respiratory system in PD patients. Wilhelm et al 6 reported a slower physiological recovery in partial pressure of carbon dioxide from voluntary hyperventilation in PD patients than in control subjects. The different type of respiratory challenge may explain some inconsistencies regarding partial pressure of carbon dioxide patterns. Physiological responses have been shown to follow different patterns depending on the challenge used. One study 21 reported a significant difference in blood pressure between panicking PD patients and nonpanicking patients or control subjects after voluntary hyperventilation, whereas no significant difference was found after 5% and 7% carbon dioxide inhalations. It would be of interest to use a crossover design, including both 35% carbon dioxide and voluntary hyperventilation as respiratory stressors, in future studies to better identify possible differences in outcome, especially in variability in respiratory and cardiovascular patterns. The procedure used to administer carbon dioxide might also influence study outcomes. Studies of 5% or 7% carbon dioxide inhalation through a canopy did, indeed, find different partial pressure of carbon dioxide values between PD patients and control subjects. 9, 22 The canopy, in itself, may affect the results by its potential anxiogenic effect. A comprehensive review 23 shows that the technique may actually influence several potentially relevant parameters, including the level of anxiety.
Another main finding of the current study is that PD patients tended to have a higher heart rate and needed more time to recover from the challenge than control subjects. Interestingly, it has been suggested that a greater respiratory irregularity may influence the heart rate in patients with PD. 16 Evidence from the literature shows that central respiratory neurons affect the vasomotor area. Respiratory neurons may gate cardiovascular efferents, producing oscillations in heart rate. 24 Both respiratory and cardiac activities are regulated by the autonomic nervous system, which elicits appropriate reactions to stressful experiences and environmental changes, affecting the psycho-physiological balance of an individual. Abnormal functioning of the respiratory system may influence the autonomic regulation of cardiac activity. A different pattern of heart rate recovery in nonmedicated PD patients suggests that the functioning of the homeostatic circuits controlled by the autonomic nervous system is likely to be less effective in these patients. The modest heart rate increase in control subjects indicates that their autonomic balance was less severely disrupted by the challenge; in fact, this group returned to baseline levels faster. As the medicated PD patients showed intermediate responses on all variables, it could be suggested that the disturbance is a state marker of panic.
Conclusions
Although the current results must be interpreted with caution, owing to the small sample sizes, they suggest that continuous recording for some minutes after the respiratory stressor may be a more sensitive technique than a single post-challenge measurement in investigating the homeostatic balance in PD. Results from the current study suggest an irregular pattern in respiration in nonmedicated PD patients and slower heart rate recovery in PD patients than in control subjects. These findings indicate that PD patients may be subject to homeostatic dysfunctions that become evident during recovery from a respiratory challenge.
Funding and Support
This work was performed without any external financing.
Résumé : Les mesures objectives et subjectives du rétablissement d'un test à 35 % de gaz carbonique
Objectifs : Étant donné que l'hyperventilation, la dyspnée, et une sensation d'étouffement sont souvent des traits fondamentaux d'une crise de panique, la respiration a été l'un des paramètres physiologiques les plus largement étudiés chez les patients souffrant de trouble panique (TP). Un sous-groupe respiratoire du TP, avec des voies étiologiques distinctes, a également été suggéré. La recherche sur la phase de rétablissement suivant un test respiratoire peut être une façon fiable d'établir une déficience respiratoire chez les patients souffrant de TP. L'objectif de la présente étude était d'examiner la phase de rétablissement d'un test à 35 % de gaz carbonique chez des patients souffrant de TP et chez des sujets témoins en santé, et de vérifier l'hypothèse d'un modèle respiratoire différent chez les patients, comparés aux témoins. Conclusions : Les résultats suggèrent que les patients souffrant de TP ont un contrôle homéostatique moins efficace après que leur équilibre physiologique a été perturbé par un stresseur respiratoire.
Méthodes
